Actavis UK: Actavis UK overcharged NHS with 12000 price hike watchdog says
Actavis UK has been accused by the Competition and Markets Authority CMA of overcharging the NHS by selling its hydrocortisone generic medication for a price more than 12000 higher than a branded version of the drug sold eight years previously.read more
Read full article »
Actavis develops, manufactures and commercializes generic, over-the-counter medicines and biologic products.
Read more